+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Esophageal Cancer Drug"

Esophageal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Esophageal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
From
Esophageal Cancer Global Market Report 2024 - Product Thumbnail Image

Esophageal Cancer Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
Esophageal Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Esophageal Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Market Spotlight: Esophageal Cancer (2020) - Product Thumbnail Image

Market Spotlight: Esophageal Cancer (2020)

  • Report
  • March 2020
  • 42 Pages
  • Global
From
From
From
From
From
From
Esophageal Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Esophageal Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 1584 Pages
  • Global
From
From
  • 15 Results (Page 1 of 1)
Loading Indicator

Esophageal cancer is a type of cancer that affects the esophagus, the tube that connects the throat to the stomach. Oncology drugs are used to treat this type of cancer, and the esophageal cancer drug market is a subset of the larger oncology drug market. These drugs are used to treat both early and advanced stages of the disease, and can include chemotherapy, targeted therapy, and immunotherapy. Esophageal cancer drugs are typically administered orally or intravenously, and can be used in combination with other treatments such as radiation therapy. The market for esophageal cancer drugs is expected to grow due to the increasing prevalence of the disease, as well as advances in drug development and delivery. Some companies in the esophageal cancer drug market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, and Pfizer. Show Less Read more